Literature DB >> 24331026

Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status.

Karen Hennessey1, Jorge Mendoza-Aldana2, Benjamin Bayutas2, Kayla Mae Lorenzo-Mariano2, Sergey Diorditsa2.   

Abstract

WHO's Western Pacific Region has the highest rates of hepatitis B virus (HBV) infection in the world; most countries have >8% prevalence of HBV chronic infection in their adult population. In 2005, Member States of the Region adopted a resolution to reduce chronic hepatitis B infection prevalence to less than 2% among children by 2012 as an interim milestone toward a regional goal of less than 1% prevalence. Country commitments to hepatitis B control and successes represent a remarkable public health achievement by preventing over 1 million chronic infections and 300,000 HBV-related deaths per birth cohort. Reported here is a review of the process and strategies for translating this public health initiative into practice including such activities as setting up an Expert Resource Panel, developing implementation guidelines, focusing on facility births while supporting efforts to reach home births, providing guidance for conducting seroprevalence surveys, and establishing a verification process.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Keywords:  Hepatitis B control; Hepatitis B virus; Vaccination

Mesh:

Year:  2013        PMID: 24331026     DOI: 10.1016/j.vaccine.2012.10.082

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth.

Authors:  Robert D Allison; Minal K Patel; Rania A Tohme
Journal:  Vaccine       Date:  2017-06-28       Impact factor: 3.641

2.  Fifty Years of Global Immunization at CDC, 1966-2015.

Authors:  Eric E Mast; Stephen L Cochi; Olen M Kew; K Lisa Cairns; Peter B Bloland; Rebecca Martin
Journal:  Public Health Rep       Date:  2016-12-19       Impact factor: 2.792

3.  Surveillance and response of hepatitis B virus in Hong Kong Special Administrative Region, 1988-2014.

Authors:  Ada Wai-Chi Lin; Ka-Hing Wong
Journal:  Western Pac Surveill Response J       Date:  2016-02-03

4.  Hepatitis B virus infection among pregnant women in Haiti: A cross-sectional serosurvey.

Authors:  Rania A Tohme; Jocelyne Andre-Alboth; Alexandra Tejada-Strop; Ran Shi; Jacques Boncy; Jeannot François; Jean Wysler Domercant; Mark Griswold; Erlantz Hyppolite; Paul Adrien; Saleem Kamili
Journal:  J Clin Virol       Date:  2016-01-28       Impact factor: 3.168

Review 5.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

6.  Hepatitis B Vaccination Coverage and Prevalence of Hepatitis B Surface Antigen Among Children in French Polynesia, 2014.

Authors:  Minal K Patel; Evelyne Le Calvez; Kathleen Wannemuehler; Jean-Marc Ségalin
Journal:  Am J Trop Med Hyg       Date:  2016-03-21       Impact factor: 2.345

7.  Disparities in Hepatitis B Virus Infection and Immunity Among New York City Asian American Patients, 1997 to 2017.

Authors:  Amy S Tang; Janice Lyu; Su Wang; Qingqing He; Perry Pong; Aaron M Harris
Journal:  Am J Public Health       Date:  2018-11       Impact factor: 9.308

Review 8.  Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.

Authors:  Lana Childs; Sigrun Roesel; Rania A Tohme
Journal:  Vaccine       Date:  2017-11-22       Impact factor: 3.641

9.  Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.

Authors:  Nino Khetsuriani; Faina Tishkova; Shamsidin Jabirov; Kathleen Wannemuehler; Saleem Kamili; Zulfiya Pirova; Liudmila Mosina; Eugene Gavrilin; Pavel Ursu; Jan Drobeniuc
Journal:  Vaccine       Date:  2015-06-10       Impact factor: 3.641

10.  Progress towards achieving hepatitis B control in the Cook Islands, Niue, Tokelau, and Kiribati.

Authors:  Minal K Patel; Kathleen Wannemuehler; Rangi Tairi; Rufina Tutai; Edna Moturi; Beia Tabwaia; Akineti Bauro Nikuata; Malae Fepuleai Etuale; Grizelda Mokoia
Journal:  Vaccine       Date:  2016-07-08       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.